Mint MIMI 深 沪
等待开盘 03-26 09:30:00 美东时间
0.2875
-0.002
-0.69%
华盛通- 最 高0.2895
- 今 开0.28
- 成交量 6.44万股
- 最 低 0.28
- 昨 收 0.2895
- 总市值 719.11万
- 52周最高 13.69
- 市盈率 静 --
- 换手率 0.26%
- 52周最低 0.25
- 委 比 0.00%
- 总股本 2501.25万
- 历史最高 13.69
- 量 比 0.61
- 振 幅 3.28%
- 历史最低 0.25
- 每 手 1
- 风险率 3.30%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Mark Offshore新增研究船Mintis 助力海上可再生能源发展
Mark Offshore已与立陶宛的克莱佩达大学（Klaipėda University）达成协议，将运营研究船Mintis，此举将扩大其船队规模，并增强...
03-25 22:33
Bitcoin Depot Announces Executive Chair & CEO Transition; Names Alex Holmes as Chairman & CEO
Bitcoin Depot announced the resignation of CEO Scott Buchanan and the appointment of Alex Holmes as CEO and Chairman. Holmes, with extensive experience in global payments and fintech, is expected to lead the company's expansion into a diversified fintech platform. Brandon Mintz will transition to a non-executive board member and advisor. Bitcoin Depot, a leading Bitcoin ATM operator, continues to grow its network and product offerings in the digi...
03-24 12:00
优必选与西门子合作量产机器人，中国技术+德国制造会否成为行业新潮流？
①上周，优必选与西门子达成战略合作协议，计划在2026年底前实现1万台人形机器人的量产能力； ②优必选希望通过与西门子的合作，填补其在制造业方面的空白，实现大规模量产目标，而西门子则将获得人形机器人相关的技术经验； ③这种中国机器人企业与德国制造业公司的搭配并非孤例。
03-23 17:06
JetBlue Airways Corporation publishes JetForward strategy presentation targeting USD 0.85-0.95 billion incremental EBIT in 2027
JetBlue Airways Corporation publishes JetForward strategy presentation targeting USD 0.85-0.95 billion incremental EBIT in 2027 JetBlue said its JetForward program is expected to deliver USD 850-950 million of incremental EBIT in 2027, following USD 305 million of incremental EBIT in 2025. JetBlue s
03-17 21:32
Elicio Therapeutics Launches $100M At-The-Market Offering Program, Replaces Prior $40M Sales Agreement
Entry into a Material Definitive Agreement.On March 16, 2026, Elicio Therapeutics, Inc. (the "Company") entered into an At Market Issuance Sales Agreement (the "Sales Agreement") with B. Riley Securities, Inc.,
03-16 21:29
港股异动 | 汇量科技绩后涨近8%，Mintegral带动业绩强劲增长，全年营收突破20亿美元
汇量科技绩后涨近8%，Mintegral带动业绩强劲增长，全年营收突破20亿美元>>
03-12 10:00
Vertex's New Kidney Drug Delivers Big Trial Win, Stock Jumps
Vertex's kidney drug delivers a "clear win" in Phase 3. Clinical success and a 6% premarket jump signal a massive milestone for VRTX.
03-10 21:24
Trump's Hormuz Gamble Is Minting A Fortune For Black-Market Oil Shippers
Shadow fleet tankers now handle nearly half of Hormuz transits as the Iran war disrupts shipping, reshaping global oil logistics and energy markets.
03-10 21:04
